We also do that bc we also think that a trial for ME/CFS might not come for BC007
Glad I'm not the only one trying to understand the whole thing...Wouldn't destroying autoantibodies render vaccine protection/immunity inert in those who need the protection?
While it sounds like a good idea for LC. I'm struggling to see how it would work for ME?
Wirth and Sheibenorgen hypothesise in their new paper that beta 2-adrenergic receptor dysfunction is of critical importance in the pathophysiology of ME/CFS, in causing vascular dysregulation.
While BC 007 has been found to have effect in Long Covid via eliminating functional pathogenic autoantibodies directed against the beta-1 adrenoceptor, Berlin Cures has also assessed it for neutralising GPCR autoantibodies against all of alpha-1 adrenergic receptor (α(1)-AR AAB), beta-1 adrenergic receptor (ß(1)-AR AAB), beta-2 adrenergic receptor (ß(2)-AR AAB) and endothelin-A-receptor (ETA AAB) and found BC 007 to be effective for all of these.
It has been supported by others researching dementia that BC 007 can neutralise GPCR autoantibodies against beta 1 and 2 adrenergic receptors in that condition.
Wirth and Sheibenorgen hypothesise in their new paper (Pathophysiology of skeletal muscle disturbances in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) that beta 2-adrenergic receptor dysfunction is of critical importance in the pathophysiology of ME/CFS, in causing vascular dysregulation, so BC 007 may have some potential for ME/CFS also.
We need EUR 800,000 to include ME/CFS patients in a promising drug research project.
WE NEED 800 000 €
for a medical study at the University Hospital Erlangen with the drug BC007 of the company "Berlin Cures" for ME/CFS patients
What is BC007?
How could they possibly raise 800k euros? that is a gigantic number! and we are all sick and broke
Can we just order it online and try it ourselves? like a crowdsourced clinical trial?
BC007 takes out certains specific autoantibodies (the immune system attacking receptors in the body).Wouldn't destroying autoantibodies render vaccine protection/immunity inert in those who need the protection?